Evoke plc (LON:EVOK - Get Free Report) shares were up 17.2% during trading on Wednesday . The stock traded as high as GBX 45.90 ($0.60) and last traded at GBX 44.30 ($0.58). Approximately 3,500,189 shares changed hands during trading, an increase of 35% from the average daily volume of 2,588,063 shares. The stock had previously closed at GBX 37.80 ($0.49).
Analyst Upgrades and Downgrades
Separately, Jefferies Financial Group reiterated a "buy" rating and issued a GBX 140 ($1.83) price target on shares of Evoke in a research note on Monday, December 16th.
Get Our Latest Stock Report on EVOK
Evoke Stock Performance
The stock has a market cap of £213.18 million, a price-to-earnings ratio of -1.19 and a beta of 0.84. The company has a 50-day simple moving average of GBX 62.59 and a two-hundred day simple moving average of GBX 62.11.
Evoke (LON:EVOK - Get Free Report) last posted its quarterly earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share (EPS) for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. As a group, sell-side analysts predict that Evoke plc will post 12.7648305 earnings per share for the current fiscal year.
Insider Buying and Selling
In other Evoke news, insider Jonathan (Jon) Mendelsohn purchased 200,000 shares of the firm's stock in a transaction that occurred on Monday, March 31st. The shares were acquired at an average cost of GBX 48 ($0.63) per share, for a total transaction of £96,000 ($125,605.13). Also, insider Andrea Gisle Joosen bought 14,572 shares of the firm's stock in a transaction on Tuesday, January 28th. The shares were acquired at an average price of GBX 70 ($0.92) per share, for a total transaction of £10,200.40 ($13,346.07). 27.00% of the stock is currently owned by insiders.
About Evoke
(
Get Free Report)
Featured Articles
Before you consider Evoke, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evoke wasn't on the list.
While Evoke currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.